Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GN Store Nord (GNNDY : OTC)

• Company Description    GN Store Nord A/S offers medical hearing instruments, professional and consumer headsets. The Company's operating segments include GN Netcom, GN ReSound and Others. GN Netcom segment sells hands-free communications solutions in the form of headsets for mobile phones and traditional phones. GN ReSound segment operates within the hearing instrument industry, and produces and sells hearing healthcare instruments and related products. It offers hearing aids and accessories under the ReSound, Beltone and Interton brand names. GN Store Nord A/S is based in Ballerup, Denmark. Number of Employees: 7,347

• Price / Volume Information    Yesterday's Closing Price: $50.00 Daily Weekly Monthly 20 Day Moving Average: 69 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 1.93 52 Week High: $64.33 52 Week Low: $36.83 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.67% 2.84% 12 Week -8.19% -9.67% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Lautrupbjerg 7 - Ballerup,G7 2750 DNK ph: 45-4575-0000 fax: - investor@gn.com http://www.gn.com

• General Corporate Information    Officers Peter Karlstromer - Chief Executive Officer Jukka Pekka Pertola - Chairman Klaus Holse - Deputy Chairman Stefan Bergfors - Chief Operations Officer Soren Jelert - Chief Financial Officer Peer Information GN Store Nord (BJCT) GN Store Nord (CADMQ) GN Store Nord (APNO) GN Store Nord (UPDC) GN Store Nord (IMTIQ) GN Store Nord (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 3621ME105 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/05/26 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 1.93 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $4.60 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.06 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/05/26

• Fundamental Ratios P/E Current FY Estimate: 10.87 Trailing 12 Months: 24.51 PEG Ratio: - Price Ratios Price/Book: 1.66 Price/Cash Flow: 7.33 Price / Sales: - EPS Growth vs. Year Ago Period: -71.95% vs. Previous Quarter: -55.77% Sales Growth vs. Year Ago Period: 1.06% vs. Previous Quarter: -2.01% ROE 12/31/25 - - 09/30/25 - 6.49 06/30/25 - 8.49 ROA 12/31/25 - - 09/30/25 - 2.32 06/30/25 - 2.99 Current Ratio 12/31/25 - - 09/30/25 - 1.14 06/30/25 - 1.14 Quick Ratio 12/31/25 - - 09/30/25 - 0.82 06/30/25 - 0.84 Operating Margin 12/31/25 - - 09/30/25 - 4.05 06/30/25 - 5.19 Net Margin 12/31/25 - - 09/30/25 - 4.05 06/30/25 - 5.19 Pre-Tax Margin 12/31/25 - - 09/30/25 - 5.60 06/30/25 - 7.05 Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - - Inventory Turnover 12/31/25 - - 09/30/25 - 3.13 06/30/25 - 2.93 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.81 06/30/25 - 0.83 Debt-to-Capital 12/31/25 - - 09/30/25 - 44.89 06/30/25 - 45.46

Powered by Zacks Investment Research ©